EP
BMRA icon

Eudaimonia Partners’s Biomerica BMRA Stock Holding History

Eudaimonia Partners’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$50K Buy
+1,375
New +$45.2K 0.01% 381
2021
Q2 		– Sell
-311
Closed -$14K – 489
2021
Q1 		$14K Buy
+311
New +$15.9K ﹤0.01% 1069

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FC
Fore Capital New York $162M AUM 14.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.29B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Eudaimonia Partners's BMRA Position: Q3 2021 in Review

Eudaimonia Partners opened a new position in Biomerica (BMRA) in Q3 2021: 1,375 shares worth $50K. The stake represents 0.01% of the portfolio and ranks #381 among its holdings. This is a return to the name: Eudaimonia Partners previously reported a position in BMRA as recently as Q1 2021.

Eudaimonia Partners first reported a position in BMRA in Q1 2021 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold BMRA as of Q3 2021.

  • Eudaimonia Partners held 1,375 shares of Biomerica worth $50K as of Q3 2021.
  • Biomerica was a new Eudaimonia Partners position in Q3 2021.
  • Biomerica made up 0.01% of Eudaimonia Partners's portfolio in Q3 2021, its #381 holding.
  • Eudaimonia Partners first reported a position in Biomerica in Q1 2021 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held Biomerica as of Q3 2021.

Based on Eudaimonia Partners's 13F filing for Q3 2021, filed 25 Oct 2021.